Monday, December 14, 2015 7:31:37 AM
Let me start by saying that there are a few items I agree with you on. First, I agree that it's CS to publish a report like this anonymously. However, I don't think that alone warrants dismissal of everything they claim without further review. Sure it's an easy out, but I think it's foolish to do so. Obviously NW feels the say way. Second, their claims about certain posters are ridiculous. Although I have often wondered if NWBO has ever contracted with a marketing/"promotional" firm and what that might entail. Anyway, I expect we can all agree on those two things so no need to waste any time there.
I would however like to look at a few of the other issues they have raised. Specifically the following:
"We suspect Powers controls a clinic providing paid “compassionate” treatments of NWBO’s unapproved DCVax." Which part of this do you find to be utter fiction? Was it their claim that Cognate has operations in Israel under Cognate Bioservices Israel Ltd. and provides treatment of DCVAX L on a pay for treatment basis? What about their claim that in 2014 the Israeli Ministry of Health ordered the center to stop providing treatments due to serious ethical and legal concerns, is that fiction? And the 2013 email from Carol Powers that describes the clinic in Israel. Is that fiction too?
Rather than making this post extremely long, I think I'll break these questions up. This post can be part 1.
Please anyone and everyone, let's debunk these claims since there seems to be a strong consensus that they are all utterly baseless and fictional. It's not like we have any other recent news from the company to discuss. It will give us something to do over the next few months while we await the investigation results.
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM